Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1966 Apr;45(4):552–561. doi: 10.1172/JCI105369

Inhibition of long-acting thyroid stimulator by thyroid particulate fractions.

G N Beall, D H Solomon
PMCID: PMC292729  PMID: 5937026

Full text

PDF
552

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ADAMS D. D., LORD J. M., STEVELY H. A. CONGENITAL THYROTOXICOSIS. Lancet. 1964 Sep 5;2(7358):497–498. doi: 10.1016/s0140-6736(64)90452-0. [DOI] [PubMed] [Google Scholar]
  2. ADAMS D. D. PATHOGENESIS OF THE HYPERTHYROIDISM OF GRAVES'S DISEASE. Br Med J. 1965 Apr 17;1(5441):1015–1019. doi: 10.1136/bmj.1.5441.1015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. ASBOE-HANSEN G. Endocrine control of connective tissue. Am J Med. 1959 Mar;26(3):470–484. doi: 10.1016/0002-9343(59)90252-9. [DOI] [PubMed] [Google Scholar]
  4. CHREMOS A. N. RELENTLESS LOCALIZED MYXEDEMA, WITH EXOPHTHALMOS, CLUBBING OF THE FINGERS AND HYPERTROPHIC OSTEOARTHROPATHY: OBSERVATIONS ON AN UNUSUAL CASE. Am J Med. 1965 Jun;38:954–961. doi: 10.1016/0002-9343(65)90016-1. [DOI] [PubMed] [Google Scholar]
  5. HELLMAN E. S., TSCHUDY D. P., ROBBINS J., RALL J. E. ELEVATION OF THE SERUM PROTEIN-BOUND IODINE IN ACUTE INTERMITTENT PORPHYRIA. J Clin Endocrinol Metab. 1963 Dec;23:1185–1191. doi: 10.1210/jcem-23-12-1185. [DOI] [PubMed] [Google Scholar]
  6. KRISS J. P., PLESHAKOV V., CHIEN J. R. ISOLATION AND IDENTIFICATION OF THE LONG-ACTING THYROID STIMULATOR AND ITS RELATION TO HYPERTHYROIDISM AND CIRCUMSCRIBED PRETIBIAL MYXEDEMA. J Clin Endocrinol Metab. 1964 Oct;24:1005–1028. doi: 10.1210/jcem-24-10-1005. [DOI] [PubMed] [Google Scholar]
  7. LEVY R. P., MCGUIRE W. L., SHAW R. K., BARTSCH G. E. EFFECT OF SPECIES DIFFERENCES OF MICE ON THE BIO-ASSAY OF THYROTROPIN. Endocrinology. 1965 May;76:890–894. doi: 10.1210/endo-76-5-890. [DOI] [PubMed] [Google Scholar]
  8. MALOOF F., SOODAK M. Intermediary metabolism of thyroid tissue and the action of drugs. Pharmacol Rev. 1963 Mar;15:43–95. [PubMed] [Google Scholar]
  9. MCKENZIE J. M. Fractionation of plasma containing the long acting thyroid stimulator. J Biol Chem. 1962 Nov;237:3571–3572. [PubMed] [Google Scholar]
  10. MCKENZIE J. M. NEONATAL GRAVES' DISEASE. J Clin Endocrinol Metab. 1964 Jul;24:660–668. doi: 10.1210/jcem-24-7-660. [DOI] [PubMed] [Google Scholar]
  11. MEEK J. C., JONES A. E., LEWIS U. J., VANDERLAAN W. P. CHARACTERIZATION OF THE LONG-ACTING THYROID STIMULATOR OF GRAVES' DISEASE. Proc Natl Acad Sci U S A. 1964 Aug;52:342–349. doi: 10.1073/pnas.52.2.342. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. MILGROM F., WITEBSKY E. Autoantibodies and autoimmune diseases. JAMA. 1962 Aug 25;181:706–716. [PubMed] [Google Scholar]
  13. McKENZIE J. M. The bioassay of thyrotropin in serum. Endocrinology. 1958 Sep;63(3):372–382. doi: 10.1210/endo-63-3-372. [DOI] [PubMed] [Google Scholar]
  14. McKenzie J. M. The gamma globulin of Graves' disease: thyroid stimulation by fraction and fragment. Trans Assoc Am Physicians. 1965;78:174–186. [PubMed] [Google Scholar]
  15. PINCHERA A., PINCHERA M. G., STANBURY J. B. THYROTROPIN AND LONG-ACTING THYROID STIMULATOR ASSAYS IN THYROID DISEASE. J Clin Endocrinol Metab. 1965 Feb;25:189–208. doi: 10.1210/jcem-25-2-189. [DOI] [PubMed] [Google Scholar]
  16. SNYDER N. J., GREEN D. E., SOLOMON D. H. GLUCOCORTICOID-INDUCED DISAPPEARANCE OF LONG-ACTING THYROID STIMULATOR IN THE OPHTHALMOPATHY OF GRAVES' DISEASE. J Clin Endocrinol Metab. 1964 Nov;24:1129–1135. doi: 10.1210/jcem-24-11-1129. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES